These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

417 related articles for article (PubMed ID: 27928097)

  • 1. Intestinal Immunity and Gut Microbiota in Atherogenesis.
    Yamashita T
    J Atheroscler Thromb; 2017 Feb; 24(2):110-119. PubMed ID: 27928097
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intestinal Immunity and Gut Microbiota as Therapeutic Targets for Preventing Atherosclerotic Cardiovascular Diseases.
    Yamashita T; Kasahara K; Emoto T; Matsumoto T; Mizoguchi T; Kitano N; Sasaki N; Hirata K
    Circ J; 2015; 79(9):1882-90. PubMed ID: 26212124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of Gut Microbiota on Cardio-Metabolic Parameters and Immunity in Coronary Artery Disease Patients with and without Type-2 Diabetes Mellitus.
    Sanchez-Alcoholado L; Castellano-Castillo D; Jordán-Martínez L; Moreno-Indias I; Cardila-Cruz P; Elena D; Muñoz-Garcia AJ; Queipo-Ortuño MI; Jimenez-Navarro M
    Front Microbiol; 2017; 8():1936. PubMed ID: 29051757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intestinal Microbiota Metabolism and Atherosclerosis.
    Liu TX; Niu HT; Zhang SY
    Chin Med J (Engl); 2015 Oct; 128(20):2805-11. PubMed ID: 26481750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gut Microbiota and Coronary Artery Disease.
    Yamashita T; Emoto T; Sasaki N; Hirata KI
    Int Heart J; 2016 Dec; 57(6):663-671. PubMed ID: 27818484
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gut Microbiota, Atherosclerosis, and Therapeutic Targets.
    Mantziaris V; Kolios G
    Crit Pathw Cardiol; 2019 Sep; 18(3):139-142. PubMed ID: 31348074
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutual Interplay of Host Immune System and Gut Microbiota in the Immunopathology of Atherosclerosis.
    Yeh CF; Chen YH; Liu SF; Kao HL; Wu MS; Yang KC; Wu WK
    Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33227973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gut microbiota in atherosclerosis: focus on trimethylamine N-oxide.
    Zhu Y; Li Q; Jiang H
    APMIS; 2020 May; 128(5):353-366. PubMed ID: 32108960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gut Microbiota and Atherosclerosis.
    Li DY; Tang WHW
    Curr Atheroscler Rep; 2017 Aug; 19(10):39. PubMed ID: 28842845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Gut microbiota and its metabolite trimethylamine-N-oxide (TMAO): a novel regulator in coronary artery disease].
    Li Y; Cui M; Sun J; Wei Q; Liu M; Zhang J; Qi H; Zhao L; Fang H; Chen Z; Lü S
    Sheng Wu Gong Cheng Xue Bao; 2021 Nov; 37(11):3745-3756. PubMed ID: 34841781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vitamin D Decreases Plasma Trimethylamine-N-oxide Level in Mice by Regulating Gut Microbiota.
    Wang X; Li X; Dong Y
    Biomed Res Int; 2020; 2020():9896743. PubMed ID: 33083493
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gut microbiome as a novel cardiovascular therapeutic target.
    Singh V; Yeoh BS; Vijay-Kumar M
    Curr Opin Pharmacol; 2016 Apr; 27():8-12. PubMed ID: 26828626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trigonelline inhibits intestinal microbial metabolism of choline and its associated cardiovascular risk.
    Anwar S; Bhandari U; Panda BP; Dubey K; Khan W; Ahmad S
    J Pharm Biomed Anal; 2018 Sep; 159():100-112. PubMed ID: 29980011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gut microbiome and its role in cardiovascular diseases.
    Ahmadmehrabi S; Tang WHW
    Curr Opin Cardiol; 2017 Nov; 32(6):761-766. PubMed ID: 29023288
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Gut Microbiota and Its Implication in the Development of Atherosclerosis and Related Cardiovascular Diseases.
    Sanchez-Rodriguez E; Egea-Zorrilla A; Plaza-Díaz J; Aragón-Vela J; Muñoz-Quezada S; Tercedor-Sánchez L; Abadia-Molina F
    Nutrients; 2020 Feb; 12(3):. PubMed ID: 32110880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of gut microbiota in atherosclerosis.
    Jonsson AL; Bäckhed F
    Nat Rev Cardiol; 2017 Feb; 14(2):79-87. PubMed ID: 27905479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trimethylamine N-Oxide Generated by the Gut Microbiota Is Associated with Vascular Inflammation: New Insights into Atherosclerosis.
    Liu Y; Dai M
    Mediators Inflamm; 2020; 2020():4634172. PubMed ID: 32148438
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contributions of the intestinal microbiome in lung immunity.
    McAleer JP; Kolls JK
    Eur J Immunol; 2018 Jan; 48(1):39-49. PubMed ID: 28776643
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trimethylamine N-Oxide Generated by the Gut Microbiota: Potential Atherosclerosis Treatment Strategies.
    Zhu B; Ren H; Xie F; An Y; Wang Y; Tan Y
    Curr Pharm Des; 2022; 28(35):2914-2919. PubMed ID: 36121073
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microbiota-Mediated Immune Regulation in Atherosclerosis.
    Eshghjoo S; Jayaraman A; Sun Y; Alaniz RC
    Molecules; 2021 Jan; 26(1):. PubMed ID: 33401401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.